CRISPR THERAPEUTICS DE&I IT'S IN OUR DNA DIVERSITY, EQUITY, AND INCLUSION
Case File Statements
GS0411: Education services, namely, providing on-line non-downloadable articles and newsletters in the field of pharmaceuticals, genetics, genome editing, gene editing, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, genetic diseases, gene therapy and cell therapy
PM0001: CRISPR THERAPEUTICS DE AND I IT IS IN OUR DNA DIVERSITY EQUITY AND INCLUSION
TF0000: as to "CRISPR THERAPEUTICS" has become distinctive of the goods/services through the applicant's substantially exclusive and continuous use of the mark in commerce that the U.S. Congress may lawfully regulate for at least the five years immediately before the date of this statement; CRISPR THERAPEUTICS has become distinctive of the goods/services as evidenced by the ownership on the Principal Register for the same mark for sufficiently similar goods/services of active U.S. Registration No(s). 6724517
GS0421: Scientific research and development, namely, gene editing for researching and developing human cells and pharmaceuticals; research and development of therapeutics pharmaceuticals using gene editing; pharmaceutical, medical, scientific, and biopharmaceutical research and development; medical laboratory services; scientific laboratory services; custom cell-line engineering services; medical and scientific research in the fields of pharmaceuticals, genetics, genome editing, gene editing, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, genetic diseases, gene therapy and cell therapy; providing medical research and scientific research information in the fields of pharmaceuticals, genetics, genome editing, gene editing, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, genetic diseases, gene therapy and cell therapy; scientific research and development services relating to targeting genetic therapies to individuals
Case File Event Statements
10/20/2022 - 2 years ago
4 - TEAS CHANGE OF CORRESPONDENCE RECEIVEDType:TCCA
10/20/2022 - 2 years ago
1 - NEW APPLICATION ENTEREDType:NWAP
10/20/2022 - 2 years ago
2 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVEDType:REAP